What is Avalo Therapeutics's total assets?

Avalo Therapeutics (AVTX) reported total assets of $99.89M in Q1 2026.

How has Avalo Therapeutics's total assets changed year-over-year?

Avalo Therapeutics's total assets decreased by 27.9% year-over-year, from $138.52M to $99.89M.

What is the long-term trend for Avalo Therapeutics's total assets?

Over 5 years (2020 to 2025), Avalo Therapeutics's total assets has grown at a 21.6% compound annual growth rate (CAGR), from $43.76M to $116.46M.

What does total assets mean?

The sum of everything the company owns — current assets, property, investments, goodwill, intangibles, and all other assets.

Avalo Therapeutics AVTX Total Assets

Total Assets at other companies

Eli LillyLLY

$116.58B+30.4%

AbbVieABBV

$136.46B+0.2%

XencorXNCR

$736.85M-18.6%

AbCellera Biologics Inc.ABCL

$1.31B-2.8%

AnaptysBio, Inc.ANAB

$329.68M-21.9%

Absci CorporationABSI

$195.59M-15.9%

Other financials

Income statement

See full

Revenue$59.0K-69.3%

Gross profit$963.0K+8,855%

Operating income-$20.9M-42.5%

Net income-$19.6M-49.3%

EPS (diluted)-$0.98+21.6%

Balance sheet

See full

Cash & equivalents$25.3M-79.8%

Total debt$328.0K-59.1%

Total equity$68.3M-44.3%

Cash flow

See full

Operating cash flow-$17.7M-87.1%

CapEx-—

Free cash flow-$15.0M-444%

Valuation

See full

Market cap$954.59M+1,800%

Enterprise value$929.6M-1,353%

P/S1,909.2×+1,868×

Profitability

See full

Gross margin182%+176pp

Operating margin-15,536.1%-17,275pp

Net margin-7,965.8%-10,750pp

FCF margin-11,123.8%-13,374pp

Returns & leverage

See full

Return on equity-88.8%—

Debt / equity0×0.0×

Current ratio7.7×-14.9×

Where this comes from

Reported directly by Avalo Therapeutics in its filing.

Tagged under the XBRL concept us-gaap:Assets.

The official record: Avalo Therapeutics’s 10-Q, filed May 13, 2026, on SEC EDGAR. View the filing →

Ask your AI about Avalo Therapeutics's total assets.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Avalo Therapeutics's total assets?: Avalo Therapeutics (AVTX) reported total assets of $99.89M in Q1 2026.
How has Avalo Therapeutics's total assets changed year-over-year?: Avalo Therapeutics's total assets decreased by 27.9% year-over-year, from $138.52M to $99.89M.
What is the long-term trend for Avalo Therapeutics's total assets?: Over 5 years (2020 to 2025), Avalo Therapeutics's total assets has grown at a 21.6% compound annual growth rate (CAGR), from $43.76M to $116.46M.
What does total assets mean?: The sum of everything the company owns — current assets, property, investments, goodwill, intangibles, and all other assets.